Biocon Hits 100M Insulin Cartridges in Malaysia

  Published 1 year ago

Biocon's Malaysian subsidiary surpassed 100 million insulin cartridges for Malaysia's MoH, serving 345,000 patients since 2016.

  • Public-private partnership drives innovation and local talent development in Malaysia's biotech ecosystem.
  • Over 345,000 patients benefited from affordable insulin access since the 2016 market entry.
  • Achievement advances Malaysia's insulin self-sufficiency and diabetes care transformation.

You might like these

Rupee Declines Amid Dollar Demand & Data

KEC Wins Rs 7,000 Cr Worth of Orders

India's Forex Reserves Dip $9.3 Billion

Surya Roshni Secures 3LPE Pipe Order, Expands Production

Aditya Birla Fashion Shares Plunge 10% on Flipkart Stake Sale

Confidence Petroleum Expands Auto LPG Network

Indian Oil Stocks Split as Crude Prices Rise

News that matters the most ⚡